Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1231.951
  • -37.737-2.97%
Trading May 14 14:22 ET
1272.287High1226.948Low
Constituent Stocks: 10Top Rising: BLUE+49.85%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
BLUEbluebird bio
4.9601.650+49.85%8.76M43.55M4.9703.3104.9904.95048.56M48.23M9.79M9.72M+34.42%+21.57%+10.96%-30.34%-25.53%-76.82%-40.53%--90.13%LossLoss1.21%Biotechnology
CRBUCaribou Biosciences
0.78380.0010+0.13%682.37K535.63K0.80000.78280.83000.770072.90M65.79M93.00M83.94M+3.13%-7.89%+0.60%-44.80%-60.41%-78.47%-50.70%--0.81%LossLoss7.67%Biotechnology
SGMOSangamo Therapeutics
0.4498-0.0102-2.22%4.40M2.03M0.49660.46000.49660.4444110.38M107.59M245.40M239.20M-30.84%-41.74%-39.07%-60.89%-76.33%-20.80%-55.90%--1.84%LossLoss11.35%Biotechnology
VRTXVertex Pharmaceuticals
420.120-11.880-2.75%1.08M456.85M432.000432.000433.410416.600107.89B107.62B256.80M256.16M-3.38%-17.54%-16.06%-9.09%-10.04%-1.98%+4.33%--0.42%LossLoss3.89%Biotechnology
AAgilent Technologies
111.630-3.790-3.28%1.31M146.85M115.030115.420115.500111.50031.83B31.71B285.10M284.05M+3.82%+3.75%+8.25%-17.26%-11.70%-25.66%-16.73%0.86%0.46%25.6025.203.47%Diagnostics & Research
APLSApellis Pharmaceuticals
16.530-0.750-4.34%1.30M21.70M17.25017.28017.26016.4102.08B1.40B125.68M84.48M-8.12%-13.95%-12.86%-41.34%-36.86%-59.88%-48.20%--1.53%LossLoss4.92%Biotechnology
CRSPCRISPR Therapeutics
35.510-1.710-4.59%1.41M51.91M37.21037.22038.64035.4803.07B3.05B86.36M85.96M+3.68%-8.17%-8.83%-32.00%-24.93%-36.26%-9.78%--1.64%LossLoss8.49%Biotechnology
BEAMBeam Therapeutics
16.920-1.130-6.26%964.06K16.76M18.12018.05018.42016.8701.70B1.54B100.56M91.03M+4.28%-15.10%-2.08%-49.48%-29.85%-28.94%-31.77%--1.06%LossLoss8.59%Biotechnology
NTLAIntellia Therapeutics
7.685-0.635-7.63%2.07M16.47M8.3408.3208.5407.650796.04M756.72M103.58M98.47M+5.42%-13.36%+4.42%-33.35%-45.77%-70.13%-34.09%--2.10%LossLoss10.70%Biotechnology
EDITEditas Medicine
1.360-0.140-9.34%1.26M1.77M1.5101.5001.5101.350113.84M113.43M83.71M83.41M+2.25%-17.58%+0.73%-21.84%-46.04%-76.06%+7.08%--1.51%LossLoss10.67%Biotechnology

News

Comments

Read more